- Diabetes, HCV new growth pillars for BMS in Japan
- Rising Japan diabetes competition tugs at Novo Nordisk
- Lilly looks to double Japan business by 2020
- Margins under pressure as GSK awaits wave of new product revenues
ONLY 0 DAY LEFT
|Stay close to your market. Renew online now to ensure uninterrupted access to:|
|SCRIP Intelligence's news and expert commentary|
|Market Data and Company Analysis (SCRIP 100, SCRIP Asia 100)|
|The Ask the Analyst Service...and more.|
Please remember to quote your order number and customer number.
You can also renew by calling: +44 (0)20 7017 5540.